|
|
Volumn 14, Issue 11, 2008, Pages 1608-1610
|
|
Episodic infliximab treatment induces infusion reactions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
AUTOANTIBODY;
AZATHIOPRINE;
CLEMASTINE;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
PREDNISOLONE;
STEROID;
TUMOR NECROSIS FACTOR ANTIBODY;
MONOCLONAL ANTIBODY;
ABSENCE OF SIDE EFFECTS;
ANTIBODY DETECTION;
ARTHRALGIA;
ASTHENIA;
CHILL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CROHN DISEASE;
DELAYED HYPERSENSITIVITY;
DIAPHORESIS;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FEVER;
DRUG INDICATION;
DRUG INDUCED HEADACHE;
DRUG MEGADOSE;
DRUG REEXPOSURE;
DRUG RESPONSE;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
FACE DISORDER;
HUMAN;
INJECTION SITE REACTION;
LETTER;
MALAISE;
MYALGIA;
NAUSEA;
NAUSEA AND VOMITING;
PARESTHESIA;
PRIORITY JOURNAL;
RASH;
SIDE EFFECT;
TACHYCARDIA;
THORAX PAIN;
COHORT ANALYSIS;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG HYPERSENSITIVITY;
FEMALE;
FOLLOW UP;
INCIDENCE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
PATHOPHYSIOLOGY;
REMISSION;
RISK ASSESSMENT;
ANTIBODIES, MONOCLONAL;
COHORT STUDIES;
CROHN DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG HYPERSENSITIVITY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
INFUSIONS, INTRAVENOUS;
MALE;
REMISSION INDUCTION;
RISK ASSESSMENT;
|
|
EID: 59249093415
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1002/ibd.20476 Document Type: Letter |
|
Times cited : (8)
|
|
References (4)
|
